Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec 1;5(1):143-148.
doi: 10.1002/jgh3.12463. eCollection 2021 Jan.

Effect of lactase on symptoms and hydrogen breath levels in lactose intolerance: A crossover placebo-controlled study

Rajiv Baijal  1 , Rakesh K Tandon  1
Affiliations

Effect of lactase on symptoms and hydrogen breath levels in lactose intolerance: A crossover placebo-controlled study

Rajiv Baijal et al. JGH Open. .

Abstract

Background and aim: The absence of lactase in the intestinal villi due to mucosal injury or genetic factors causes undigested lactose to reach the colon where it is fermented. Lactose intolerance is diagnosed based on clinical symptoms like bloating, abdominal pain and flatulence, lactose hydrogen breath test (HBT), and lactose tolerance test. No Indian studies are available on the use of lactase supplements. The aim was to study the effect of lactase chewable tablets on clinical symptoms and hydrogen breath excretion in patients with lactose intolerance.

Methods: This was a randomized, double-blind, crossover placebo-controlled trial to study the effect of lactase tablets on symptoms and hydrogen breath levels in adults with lactose intolerance, confirmed by Lactose HBT. Clinical symptom severity was recorded using a visual analog scale, and HBT was performed every 30 min for 180 min. As it was a crossover design, the same patients were tested with both lactase and placebo, acting as their own controls with a washout period of 1 week between visits.

Results: Forty-seven patients (mean age 33.6 years; 30 males) with lactose intolerance formed the study group. Clinical symptoms, mean clinical score (P < 0.05), and mean hydrogen breath levels (P < 0.05) were improved when the patients were given lactase. Reduction in cumulative hydrogen breath level over 180 min was 55% when patients received lactase compared to placebo.

Conclusions: Orally supplemented lactase enzyme significantly reduced the clinical symptoms and hydrogen breath excretion in patients with lactose intolerance.

Keywords: lactase enzyme; lactose hydrogen breath test; lactose intolerance.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow chart showing the trial methodology.
Figure 2
Figure 2
Comparison of mean clinical scores between lactase and placebo groups after crossover analysis (n = 47). formula image, Placebo; formula image, lactase.
Figure 3
Figure 3
Comparison of hydrogen breath levels between lactase and placebo groups after crossover analysis (n = 47). formula image, Placebo; formula image, lactase.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Suchy FJ, Brannon PM, Carpenter TO et al National Institutes of Health Consensus Development Conference: lactose intolerance and health. Ann. Intern. Med. 2010; 152: 792–6. - PubMed
    1. Di Rienzo T, D'Angelo G, D'aversa F et al Lactose intolerance: from diagnosis to correct management. Eur. Rev. Med. Pharmacol. Sci. 2013; 17: 18–25. - PubMed
    1. Leonardi M, Gerbault P, Thomas MG, Burger J. The evolution of lactase persistence in Europe. A synthesis of archaeological and genetic evidence. Int. Dairy J. 2012; 22: 88–97.
    1. Swagerty DL Jr, Walling AD, Klein RM. Lactose intolerance. Am. Fam. Physician. 2002; 65: 1845–50. - PubMed
    1. Babu J, Kumar S, Babu P, Prasad JH, Ghoshal UC. Frequency of lactose malabsorption among healthy Southern and Northern Indian populations by genetic analysis and lactose hydrogen breath and tolerance tests. Am. J. Clin. Nutr. 2010; 91: 140–6. - PubMed